NY-ESO-1 (87-111) is a pan-MHC class II-restricted peptide that interacts with various HLA-DR and HLA-DP4 molecules, inducing activation of CD4+ T cells with Th1-type and Th-2 Th0-type responses, when presented in conjunction with HLA-DR and HLA-DP4 molecules.